Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani.
Drug Target Discovery and Development Division, Central Drug Research Institute, Lucknow, India.
Journal Article: Protein Expression and Purification (impact factor: 1.56). 01/2005; 38(2):228-36. DOI: 10.1016/j.pep.2004.08.015
Abstract
Source: PubMed
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Similar publications
Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani
Protein Expression and Purification.
In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis.
Antimicrobial agents and chemotherapy. 55(2):659-66.
Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani.
Biological chemistry. 392(12):1113-22.
Identification of a novel dihydrodaidzein racemase, that is essential for equol biosynthesis from daidzein in Lactococcus strain 20-92.
Applied and environmental microbiology.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Science & Research Jobs
Postdoctoral Fellow - Root Phenotyping
Position: PostDoc Position
Employer: Commonwealth Scientific and Industr...
PRAS-Healthcare-Scientist for Mechanical Engieering
Position: Engineer
Employer: Philips (China) Investment Co.,Ltd

